The company’s abstract, titled “Osteoinductivity and Osteogenicity of Leading Allograft Bone Products,” analyzed the bone forming potential of the company’s two allograft products, OsteoAMP Allogeneic Morphogenetic Protein and Osteocel Plus.
The study has been submitted for an additional peer review.
More Articles on Devices:
DePuy Extends Brainlab Collaboration on Spine Instrumentation
Thompson Surgical Instruments Celebrates 50 Years, Launches New Products
K2M Launches SANTORINI Cage System for Spinal Vertebral Collapse, Damage
